IFNA1 and esophageal squamous cell carcinoma: Additionally, a phase II trial indicates that a combination of 5-fluorouracil (5-FU), cisplatin and IFN α results in a high response rate in advanced esophageal squamous cell carcinoma (SCC) [33].